Loading…

Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife

PurposeFor the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2022-06, Vol.12, p.860641-860641
Main Authors: Ku, Ki Man, Lam, Bing, Wu, Vincent W. C., Chan, Kwok Ting, Chan, Chloe Y. Y., Cheng, H. C., Yuen, Kamy M. Y., Cai, Jing
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c392t-247356141695ea6fe8a88b39bee82f21435dd29a2c99d487418af596ac4a111a3
container_end_page 860641
container_issue
container_start_page 860641
container_title Frontiers in oncology
container_volume 12
creator Ku, Ki Man
Lam, Bing
Wu, Vincent W. C.
Chan, Kwok Ting
Chan, Chloe Y. Y.
Cheng, H. C.
Yuen, Kamy M. Y.
Cai, Jing
description PurposeFor the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions using a pre-procedure planning system and performing virtual simulation before implantation. The objectives were 1) to reduce the duration of the FM implantation procedure, 2) to reduce the radiation exposure in dose area product (DAP) (dGy*cm2) to patients, and 3) to increase the number of FMs implanted around the tumour. Methods and MaterialsThis study is retrospective, single-centre, and observational in nature. A total of 32 patients were divided into two groups. In Group 1, 18 patients underwent conventional VBN FM implantation. In Group 2, 14 patients underwent additional pre-procedure planning and simulation. The steps of pre-procedure planning include 1) importing CT images into the treatment planning system (Eclipse, Varian Medical Systems, Inc.) and delineating five to six FMs in their ideal virtual positions and 2) copying the FM configuration into VBN planning software (LungPoint Bronchus Medical, Inc.) for verification and simulation. Finally, the verified FMs were deployed through VBN with the guidance of the LungPoint planning software. ResultsA total of 162 FMs were implanted among 35 lesions in 32 patients aged from 37 to 92 (median = 66; 16 men and 16 women). Results showed that 1) the average FM insertion time was shortened from 41 min (SD = 2.05) to 23 min (SD = 1.25), p = 0.00; 2) the average absorbed dose of patients in DAP was decreased from 67.4 cGy*cm2 (SD = 14.48) to 25.3 cGy*cm2 (SD = 3.82), p = 0.01 (1-tailed); and 3) the average number of FMs implanted around the tumour was increased from 4.7 (SD = 0.84) to 5.6 (SD = 0.76), p = 0.00 (1-tailed). ConclusionPre-procedure planning reduces the FM implantation duration from 41.1 to 22.9 min, reduces the radiation exposure in DAP from 67.4 to 25.3 dGy*cm2, and increases the number of FMs inserted around the tumour from 4.7 to 5.6.
doi_str_mv 10.3389/fonc.2022.860641
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_56c7fc4a27424e7cb3f464341229aa15</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_56c7fc4a27424e7cb3f464341229aa15</doaj_id><sourcerecordid>2685031867</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-247356141695ea6fe8a88b39bee82f21435dd29a2c99d487418af596ac4a111a3</originalsourceid><addsrcrecordid>eNpVkstu3CAUhq2qUROl2XfJshtPzcUYNpXaUdKOMk2ymF526BjDDKkNU7BHyoPkfcvUUZWwAc75z3e4_EXxDlcLSoX8YIPXC1IRshC84gy_Ks4IoayUjP56_Wx9WlykdF_lwesKV_RNcUrrRtS4EWfF47J33mno0eUB-glGFzwKFl25btIuh79B_G0iuoumvOvBe-e3yIaIfrg4Tjn_OeZj7ELSYe80uoGD286Q1bDP-nHeOI_WU67cTEOYMi1HjR8T2kQDo-nQTzfu0PKhNfHaO2veFicW-mQunubz4vvV5Wb5tVzfflktP61LTSUZS8IaWnPMMJe1AW6NACFaKltjBLEEM1p3HZFAtJQdEw3DAmwtOWgGGGOg58Vq5nYB7tU-ugHigwrg1L9AiFsFcXS6N6rmurG5jjSMMNPollrGGWWY5AaA68z6OLP2UzuYTuf7RehfQF9mvNupbTgoSVj-GJoB758AMfyZTBrV4JI2fX5FE6akCBdZhgVvsrSapTqGlKKx_9vgSh3NoY7mUEdzqNkc9C-FkK6v</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2685031867</pqid></control><display><type>article</type><title>Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife</title><source>PMC (PubMed Central)</source><creator>Ku, Ki Man ; Lam, Bing ; Wu, Vincent W. C. ; Chan, Kwok Ting ; Chan, Chloe Y. Y. ; Cheng, H. C. ; Yuen, Kamy M. Y. ; Cai, Jing</creator><creatorcontrib>Ku, Ki Man ; Lam, Bing ; Wu, Vincent W. C. ; Chan, Kwok Ting ; Chan, Chloe Y. Y. ; Cheng, H. C. ; Yuen, Kamy M. Y. ; Cai, Jing</creatorcontrib><description>PurposeFor the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions using a pre-procedure planning system and performing virtual simulation before implantation. The objectives were 1) to reduce the duration of the FM implantation procedure, 2) to reduce the radiation exposure in dose area product (DAP) (dGy*cm2) to patients, and 3) to increase the number of FMs implanted around the tumour. Methods and MaterialsThis study is retrospective, single-centre, and observational in nature. A total of 32 patients were divided into two groups. In Group 1, 18 patients underwent conventional VBN FM implantation. In Group 2, 14 patients underwent additional pre-procedure planning and simulation. The steps of pre-procedure planning include 1) importing CT images into the treatment planning system (Eclipse, Varian Medical Systems, Inc.) and delineating five to six FMs in their ideal virtual positions and 2) copying the FM configuration into VBN planning software (LungPoint Bronchus Medical, Inc.) for verification and simulation. Finally, the verified FMs were deployed through VBN with the guidance of the LungPoint planning software. ResultsA total of 162 FMs were implanted among 35 lesions in 32 patients aged from 37 to 92 (median = 66; 16 men and 16 women). Results showed that 1) the average FM insertion time was shortened from 41 min (SD = 2.05) to 23 min (SD = 1.25), p = 0.00; 2) the average absorbed dose of patients in DAP was decreased from 67.4 cGy*cm2 (SD = 14.48) to 25.3 cGy*cm2 (SD = 3.82), p = 0.01 (1-tailed); and 3) the average number of FMs implanted around the tumour was increased from 4.7 (SD = 0.84) to 5.6 (SD = 0.76), p = 0.00 (1-tailed). ConclusionPre-procedure planning reduces the FM implantation duration from 41.1 to 22.9 min, reduces the radiation exposure in DAP from 67.4 to 25.3 dGy*cm2, and increases the number of FMs inserted around the tumour from 4.7 to 5.6.</description><identifier>ISSN: 2234-943X</identifier><identifier>EISSN: 2234-943X</identifier><identifier>DOI: 10.3389/fonc.2022.860641</identifier><identifier>PMID: 35785178</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>CyberKnife ; dose area product ; fiducial marker ; lung cancer ; Oncology ; virtual bronchoscopic navigation</subject><ispartof>Frontiers in oncology, 2022-06, Vol.12, p.860641-860641</ispartof><rights>Copyright © 2022 Ku, Lam, Wu, Chan, Chan, Cheng, Yuen and Cai 2022 Ku, Lam, Wu, Chan, Chan, Cheng, Yuen and Cai</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c392t-247356141695ea6fe8a88b39bee82f21435dd29a2c99d487418af596ac4a111a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246503/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246503/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27915,27916,53782,53784</link.rule.ids></links><search><creatorcontrib>Ku, Ki Man</creatorcontrib><creatorcontrib>Lam, Bing</creatorcontrib><creatorcontrib>Wu, Vincent W. C.</creatorcontrib><creatorcontrib>Chan, Kwok Ting</creatorcontrib><creatorcontrib>Chan, Chloe Y. Y.</creatorcontrib><creatorcontrib>Cheng, H. C.</creatorcontrib><creatorcontrib>Yuen, Kamy M. Y.</creatorcontrib><creatorcontrib>Cai, Jing</creatorcontrib><title>Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife</title><title>Frontiers in oncology</title><description>PurposeFor the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions using a pre-procedure planning system and performing virtual simulation before implantation. The objectives were 1) to reduce the duration of the FM implantation procedure, 2) to reduce the radiation exposure in dose area product (DAP) (dGy*cm2) to patients, and 3) to increase the number of FMs implanted around the tumour. Methods and MaterialsThis study is retrospective, single-centre, and observational in nature. A total of 32 patients were divided into two groups. In Group 1, 18 patients underwent conventional VBN FM implantation. In Group 2, 14 patients underwent additional pre-procedure planning and simulation. The steps of pre-procedure planning include 1) importing CT images into the treatment planning system (Eclipse, Varian Medical Systems, Inc.) and delineating five to six FMs in their ideal virtual positions and 2) copying the FM configuration into VBN planning software (LungPoint Bronchus Medical, Inc.) for verification and simulation. Finally, the verified FMs were deployed through VBN with the guidance of the LungPoint planning software. ResultsA total of 162 FMs were implanted among 35 lesions in 32 patients aged from 37 to 92 (median = 66; 16 men and 16 women). Results showed that 1) the average FM insertion time was shortened from 41 min (SD = 2.05) to 23 min (SD = 1.25), p = 0.00; 2) the average absorbed dose of patients in DAP was decreased from 67.4 cGy*cm2 (SD = 14.48) to 25.3 cGy*cm2 (SD = 3.82), p = 0.01 (1-tailed); and 3) the average number of FMs implanted around the tumour was increased from 4.7 (SD = 0.84) to 5.6 (SD = 0.76), p = 0.00 (1-tailed). ConclusionPre-procedure planning reduces the FM implantation duration from 41.1 to 22.9 min, reduces the radiation exposure in DAP from 67.4 to 25.3 dGy*cm2, and increases the number of FMs inserted around the tumour from 4.7 to 5.6.</description><subject>CyberKnife</subject><subject>dose area product</subject><subject>fiducial marker</subject><subject>lung cancer</subject><subject>Oncology</subject><subject>virtual bronchoscopic navigation</subject><issn>2234-943X</issn><issn>2234-943X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkstu3CAUhq2qUROl2XfJshtPzcUYNpXaUdKOMk2ymF526BjDDKkNU7BHyoPkfcvUUZWwAc75z3e4_EXxDlcLSoX8YIPXC1IRshC84gy_Ks4IoayUjP56_Wx9WlykdF_lwesKV_RNcUrrRtS4EWfF47J33mno0eUB-glGFzwKFl25btIuh79B_G0iuoumvOvBe-e3yIaIfrg4Tjn_OeZj7ELSYe80uoGD286Q1bDP-nHeOI_WU67cTEOYMi1HjR8T2kQDo-nQTzfu0PKhNfHaO2veFicW-mQunubz4vvV5Wb5tVzfflktP61LTSUZS8IaWnPMMJe1AW6NACFaKltjBLEEM1p3HZFAtJQdEw3DAmwtOWgGGGOg58Vq5nYB7tU-ugHigwrg1L9AiFsFcXS6N6rmurG5jjSMMNPollrGGWWY5AaA68z6OLP2UzuYTuf7RehfQF9mvNupbTgoSVj-GJoB758AMfyZTBrV4JI2fX5FE6akCBdZhgVvsrSapTqGlKKx_9vgSh3NoY7mUEdzqNkc9C-FkK6v</recordid><startdate>20220616</startdate><enddate>20220616</enddate><creator>Ku, Ki Man</creator><creator>Lam, Bing</creator><creator>Wu, Vincent W. C.</creator><creator>Chan, Kwok Ting</creator><creator>Chan, Chloe Y. Y.</creator><creator>Cheng, H. C.</creator><creator>Yuen, Kamy M. Y.</creator><creator>Cai, Jing</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220616</creationdate><title>Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife</title><author>Ku, Ki Man ; Lam, Bing ; Wu, Vincent W. C. ; Chan, Kwok Ting ; Chan, Chloe Y. Y. ; Cheng, H. C. ; Yuen, Kamy M. Y. ; Cai, Jing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-247356141695ea6fe8a88b39bee82f21435dd29a2c99d487418af596ac4a111a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CyberKnife</topic><topic>dose area product</topic><topic>fiducial marker</topic><topic>lung cancer</topic><topic>Oncology</topic><topic>virtual bronchoscopic navigation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ku, Ki Man</creatorcontrib><creatorcontrib>Lam, Bing</creatorcontrib><creatorcontrib>Wu, Vincent W. C.</creatorcontrib><creatorcontrib>Chan, Kwok Ting</creatorcontrib><creatorcontrib>Chan, Chloe Y. Y.</creatorcontrib><creatorcontrib>Cheng, H. C.</creatorcontrib><creatorcontrib>Yuen, Kamy M. Y.</creatorcontrib><creatorcontrib>Cai, Jing</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ku, Ki Man</au><au>Lam, Bing</au><au>Wu, Vincent W. C.</au><au>Chan, Kwok Ting</au><au>Chan, Chloe Y. Y.</au><au>Cheng, H. C.</au><au>Yuen, Kamy M. Y.</au><au>Cai, Jing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife</atitle><jtitle>Frontiers in oncology</jtitle><date>2022-06-16</date><risdate>2022</risdate><volume>12</volume><spage>860641</spage><epage>860641</epage><pages>860641-860641</pages><issn>2234-943X</issn><eissn>2234-943X</eissn><abstract>PurposeFor the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions using a pre-procedure planning system and performing virtual simulation before implantation. The objectives were 1) to reduce the duration of the FM implantation procedure, 2) to reduce the radiation exposure in dose area product (DAP) (dGy*cm2) to patients, and 3) to increase the number of FMs implanted around the tumour. Methods and MaterialsThis study is retrospective, single-centre, and observational in nature. A total of 32 patients were divided into two groups. In Group 1, 18 patients underwent conventional VBN FM implantation. In Group 2, 14 patients underwent additional pre-procedure planning and simulation. The steps of pre-procedure planning include 1) importing CT images into the treatment planning system (Eclipse, Varian Medical Systems, Inc.) and delineating five to six FMs in their ideal virtual positions and 2) copying the FM configuration into VBN planning software (LungPoint Bronchus Medical, Inc.) for verification and simulation. Finally, the verified FMs were deployed through VBN with the guidance of the LungPoint planning software. ResultsA total of 162 FMs were implanted among 35 lesions in 32 patients aged from 37 to 92 (median = 66; 16 men and 16 women). Results showed that 1) the average FM insertion time was shortened from 41 min (SD = 2.05) to 23 min (SD = 1.25), p = 0.00; 2) the average absorbed dose of patients in DAP was decreased from 67.4 cGy*cm2 (SD = 14.48) to 25.3 cGy*cm2 (SD = 3.82), p = 0.01 (1-tailed); and 3) the average number of FMs implanted around the tumour was increased from 4.7 (SD = 0.84) to 5.6 (SD = 0.76), p = 0.00 (1-tailed). ConclusionPre-procedure planning reduces the FM implantation duration from 41.1 to 22.9 min, reduces the radiation exposure in DAP from 67.4 to 25.3 dGy*cm2, and increases the number of FMs inserted around the tumour from 4.7 to 5.6.</abstract><pub>Frontiers Media S.A</pub><pmid>35785178</pmid><doi>10.3389/fonc.2022.860641</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2234-943X
ispartof Frontiers in oncology, 2022-06, Vol.12, p.860641-860641
issn 2234-943X
2234-943X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_56c7fc4a27424e7cb3f464341229aa15
source PMC (PubMed Central)
subjects CyberKnife
dose area product
fiducial marker
lung cancer
Oncology
virtual bronchoscopic navigation
title Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T22%3A37%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Evaluation%20of%20Fiducial%20Marker%20Pre-Planning%20for%20Virtual%20Bronchoscopic%20Navigation%20Implantation%20in%20Lung%20Tumour%20Patients%20Treated%20With%20CyberKnife&rft.jtitle=Frontiers%20in%20oncology&rft.au=Ku,%20Ki%20Man&rft.date=2022-06-16&rft.volume=12&rft.spage=860641&rft.epage=860641&rft.pages=860641-860641&rft.issn=2234-943X&rft.eissn=2234-943X&rft_id=info:doi/10.3389/fonc.2022.860641&rft_dat=%3Cproquest_doaj_%3E2685031867%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-247356141695ea6fe8a88b39bee82f21435dd29a2c99d487418af596ac4a111a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2685031867&rft_id=info:pmid/35785178&rfr_iscdi=true